GPT and type 2 diabetes mellitus: In a retrospective observational study of patients with MASLD and type 2 diabetes, AST and γ-GTP levels were significantly reduced 16 weeks after imeglimin administration, whereas ALT and FIB-4 levels remained unchanged [17].